Phase | Originator | Licensee | Common name | Specificity target | Target disease |
3 | UCB (Celltech) | Pfizer | CMC-544 | anti-CD22 | ALL, DLBCL |
Phase | Originator | Licensee | Common name | Specificity target | Target disease |
3 | UCB (Celltech) | Pfizer | CMC-544 | anti-CD22 | ALL, DLBCL |